1-9 of 9
AKIRA YOSHIDA
Close
Sort by
Journal Articles

YM155 Exerts Potent Cytotoxic Activity Against Quiescent (G0/G1) Multiple Myeloma and Bortezomib Resistant Cells Via Inhibition of Mcl-1 and Survivin

Miyuki Ookura, MD, Tatsuya Fujii, Shinji Kishi, MD PhD, Hiroko Shigemi, MDPhD, Naoko Hosono, MDPhD, Takahiro Yamauchi, MD PhD, Takanori Ueda, MD PhD, Akira Yoshida, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3023.
https://doi.org/10.1182/blood.V126.23.3023.3023
Published: 2015
Journal Articles

Go6976, a Potent FLT3 Kinase Inhibitor, Exerts Antiproliferative Activity Against Acute Myeloid Leukemia Via Inhibition Of Survivin and Mcl-1 In The Presence Of Human Serum

Akira Yoshida, MD, PhD, Kouichi Zokumasu, Takanori Ueda, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3839.
https://doi.org/10.1182/blood.V122.21.3839.3839
Published: 2013
Journal Articles

Marked Upregulations of Survivin and Aurora-B Kinase Are Associated with Disease Progression in the Myelodysplastic Syndromes,

Akira Yoshida, MD, PhD, Kouichi Zokumasu, Takahiro Yamauchi, MD, PhD, Kazutaka Takagi, MD, PhD, Shinji Kishi, MD, PhD, Yoshimasa Urasaki, MD, PhD, Kaoru Tohyama, MD, PhD, Takanori Ueda, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3823.
https://doi.org/10.1182/blood.V118.21.3823.3823
Published: 2011
Journal Articles

Prominent Elevation of Survivin Expression in High-Risk Myelodysplastic Syndrome.

Akira Yoshida, MD, PhD, Saki Tanaka, Takahiro Yamauchi, Kazutaka Takagi, Shinji Kishi, MD, PhD, Yoshimasa Urasaki, MD, PhD, Kaoru Tohyama, Takanori Ueda, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4842.
https://doi.org/10.1182/blood.V114.22.4842.4842
Published: 2009
Journal Articles

Unique Resistance Mechanism to Dexamethasone by Glutathione S-Transferase M1 Involving p38 MAPK and NF-κB Pathways, Possible Prognostic Role for Childhood ALL.

Naoko Hosono, MD, Shinji Kishi, MD., PhD., Sumiko Iho, PhD., Yoshimasa Urasaki, MD., PhD., Akira Yoshida, MD., PhD., Hisanori Kurooka, PhD., Yoshifumi Yokota, MD., PhD., Takanori Ueda, MD., PhD.
Journal: Blood
Blood (2007) 110 (11): 2375.
https://doi.org/10.1182/blood.V110.11.2375.2375
Published: 2007
Journal Articles

G-6-PD Manchester: A New Variant Associated With Chronic Nonspherocytic Hemolytic Anemia

Gillian Milner, B.M., Ph.D., M.R.C. Path., Irvine W. Delamore, Ph.D., F.R.C.P., Akira Yoshida, M.D.
Journal: Blood
Blood (1974) 43 (2): 271–276.
https://doi.org/10.1182/blood.V43.2.271.271
Published: 1974
Journal Articles

Regulation of Glucose-6-Phosphate Dehydrogenase Activity in Red Blood Cells From Hemolytic and Nonhemolytic Variant Subjects

Akira Yoshida, Ph.D., Mei Lin, M.S.
Journal: Blood
Blood (1973) 41 (6): 877–891.
https://doi.org/10.1182/blood.V41.6.877.877
Published: 1973
Journal Articles

Hemoglobin Köln Disease Occurring as a Fresh Mutation: Erythrocyte Metabolism and Survival

DENIS R. MILLER, M.D., ROBERT I. WEED, M.D., GEORGE STAMATOYANNOPOULOS, M.D., AKIRA YOSHIDA, PH.D.
Journal: Blood
Blood (1971) 38 (6): 715–729.
https://doi.org/10.1182/blood.V38.6.715.715
Published: 1971
Journal Articles

A Philippino Glucose-6-Phosphate Dehydrogenase Variant (G6PD Union) With Enzyme Deficiency and Altered Substrate Specificity

AKIRA YOSHIDA, M.D., ERNST W. BAUR, M.D., ARNO G. MOUTLSKY, M.D.
Journal: Blood
Blood (1970) 35 (4): 506–513.
https://doi.org/10.1182/blood.V35.4.506.506
Published: 1970